2,519 followers
Open Access UCL Research: Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study https://t.co/ReBt2EY7Dh
Open Access UCL Research: Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study https://t.co/ReBt2EY7Dh
Dirix, L. Y.-Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast c... https://t.co/v63wU6ilOQ
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN… https://t.co/wVyOhBEDA3 https://t.co/cryGdFtvBa